BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10594296)

  • 1. Identification of metal allergens in the local lymph node assay.
    Basketter DA; Lea LJ; Cooper KJ; Ryan CA; Gerberick GF; Dearman RJ; Kimber I
    Am J Contact Dermat; 1999 Dec; 10(4):207-12. PubMed ID: 10594296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of vehicle on assessment of relative skin sensitization potency of 1,4-dihydroquinone in the local lymph node assay.
    Lea LJ; Warbrick EV; Dearman RJ; Kimber I; Basketter DA
    Am J Contact Dermat; 1999 Dec; 10(4):213-8. PubMed ID: 10594297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a peptide reactivity assay for screening contact allergens.
    Gerberick GF; Vassallo JD; Bailey RE; Chaney JG; Morrall SW; Lepoittevin JP
    Toxicol Sci; 2004 Oct; 81(2):332-43. PubMed ID: 15254333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The local lymph node assay and skin sensitization testing.
    Kimber I; Dearman RJ
    Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ethanol:diethylphthalate as a vehicle for the local lymph node assay.
    Betts CJ; Beresford L; Dearman RJ; Lalko J; Api AP; Kimber I
    Contact Dermatitis; 2007 Feb; 56(2):70-5. PubMed ID: 17244073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
    Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
    Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The local lymph node assay and the assessment of relative potency: status of validation.
    Basketter DA; Gerberick F; Kimber I
    Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug allergenicity: possible use of the local lymph node assay.
    Warbrick EV; Dearman RJ; Kimber I
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):60-5. PubMed ID: 11727324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
    Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.